Category

JDD Webinars

Treating Acne in Adolescents and Young Adults

By Acne, JDD Webinars No Comments

JDD Multimedia

JDD Webinars

Register Now to Earn 1.0 CE Credit! 

Sign Up Now!

Treating Acne in Adolescents and Young Adults

Featuring Leon H. Kircik, MD, Anthony J. Mancini, MD, FAAP, FAAD, Adelaide A. Hebert, MD

Space Is Limited - Sign Up Now

Sign Up Now!

Earn 1.0 CE Credit:

Join Drs. Leon H. Kirick, Anthony Mancini, and Adelaide Hebert, as they  explore the categorization and grading of acne by age of onset in children and adolescents. They will also review and discuss new and evolving acne treatment strategies that offer optimal outcomes in children and young adults presenting with acne.

Upon completion of this live, internet-based CE activity, participants should be able to:

  • Appreciate the updated pediatric care classification, including appropriate evaluations and treatment, when needed 
  • Review acne treatment strategies offering optimal outcomes for pre-adolescents and adolescents with acne.

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Anthony J. Mancini, MD, FAAP, FAAD
Head, Division of Dermatology, Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine
Chicago, Illinois
Adelaide A. Hebert, MD
Chief of Pediatric Dermatology
McGovern School of Medicine
Childrens’ Memorial Hermann Hospital
Houston, Texas
Sign Up Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Recognizing Nuances in the Diagnosis & Management of Acne in Skin of Color Patients

By Acne, JDD Webinars, Skin of Color No Comments

JDD Multimedia

JDD Webinars

Register Now to Earn 1.0 CE Credit! 

Sign Up Now!

Recognizing Nuances in the Diagnosis & Management of Acne in Skin of Color Patients

Featuring Leon Kircik, MD & Andrew Alexis, MD, MPH

Space Is Limited - Sign Up Now

Sign Up Now!

Earn 1.0 CE Credit:

Join Dr. Leon H. Kircik and Andrew Alexis, MD, MPH as they discuss they nuances in the diagnosis and management of acne in skin of color patients.

Upon completion of this enduring, internet-based webinar, participants should be able to:

  • Summarize the role of androgen and androgen receptors in the development and management of acne in skin of color patients
  • Recognize clinical nuances in acne grade and severity in skin of color patients
  • Differentiate therapeutic approaches in treating acne in patients with darker skin vs. lighter skin
  • Discuss new therapies in development for the management of acne

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Andrew Alexis, MD, MPH
Chair, Department of Dermatology
Mount Sinai West and Mount Sinai Morningside
Professor, Icahn School of Medicine at Mount Sinai
New York, New York
Sign Up Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Thinning Hair Through Menopause: Results of a First-of-its-Kind Randomized Controlled Trial on Nutraceuticals

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

In this free live webinar, Dr. Glynis Ablon will discuss age and menopause related hair changes and she will present results from two studies on the clinical benefits of standardized nutraceuticals on hair in women going through the menopausal transition and beyond.

Register Now

Register Now!
Supported By

 

Thinning Hair Through Menopause: Results of a First-of-its-Kind Randomized Controlled Trial on Nutraceuticals

Featuring Dr. Glynis Ablon

Register Now

Register Now!

We understand that hair loss and thinning is an accumulation of multiple factors, this presentation will focus on hair thinning during menopause and results from a first-of-its-kind randomized controlled trial on nutraceuticals.

Dr. Glynis Ablon will discuss age and menopause related hair changes and she will present results from two studies on the clinical benefits of standardized nutraceuticals on hair in women going through the menopausal transition and beyond.

Faculty

Glynis Ablon, M.D., FAAD

Glynis Ablon, M.D., FAAD, is a dermatologist and cosmetic surgeon, and Associate Clinical Professor of Dermatology at UCLA. She founded the Ablon Skin Institute and Research Center 20 years ago in Manhattan Beach, where in addition to a thriving medical and cosmetic practice, she guides pioneering research in dermatology products and procedures. Dr. Ablon is a Fellow of the American Academy of Dermatology, American Academy of Liposuction Surgery, American Society for Laser Medicine and Surgery, and American Society for Dermatologic Surgery, while on staff at Providence Little Company of Mary Medical Center and UCLA. She has also appeared as an on-camera medical consultant for the Emmy Award Winning The Doctors television show, as well as Entertainment Tonight, ABC, NBC, CBS, KCAL and Lifetime.

 

In her book What’s Stressing Your Face: A Skin Doctor’s Guide to Healing Stress-Induced Facial Conditions, Dr. Ablon provides comprehensive evaluations of case stories and her own personal experience of skin conditions and their relationships to stress in our daily lives. Her talk, What’s Stressing Your Face, will address how stress, facial skin problems, and age related conditions can show up, and offers effective healing methods combining holistic techniques and cutting-edge products and procedures to treat, control and reduce these conditions. Learn techniques to take control of your stress before it takes control of your skin.

 

Register Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Watch On Demand: Proper Hydration and Exfoliation Support Treatments for Patients with Inflammatory Skin Conditions

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

Watch On Demand

This exclusive #SkinChat webinar originally aired on December 16th, 2020. Dr. Leon H. Kircik and Professor Petra Staubach-Renz  discussed the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

Proper hydration and exfoliation support treatments for patients with inflammatory skin conditions

By Heather Onorati

People with conditions characterized by an impaired skin barrier and hyperkeratosis can benefit from incorporating a uniquely formulated skincare regimen with other recommended treatments, according to two experts who shared insights into how a variety of ingredients work to complement therapeutic selections and improve outcomes for these patients. 

In a recent webinar, Professor Petra Staubach-Renz, department of dermatology, University Medical Center, Mainz, Germany, and Leon H. Kircik, M.D., Icahn School of Medicine at Mount Sinai, New York, delivered very relevant presentations on adjunctive skincare solutions for hyperkeratolytic conditions.

Dry, rough, uneven skin is a common symptom for many of these hyperkeratolytic conditions, according to Prof. Staubach-Renz. This is characterized by a build-up of cells on the skin’s surface that create an irregular, thick texture. Hyperkeratosis commonly presents in patients with conditions like keratosis pilaris, ichythyosis, psoriasis, and atopic dermatitis.  

More than 40% of people around the world suffer from keratosis pilaris, also called follicular keratosis, Prof. Staubach-Renz noted. In addition, there are more than 125 million people globally who suffer from psoriasis, 60% of which report that the disease significantly affects their lives, Dr. Kircik added. The biggest problems that those affected report are the appearance of the skin and the scaling, which result from transepidermal water loss and a dysfunctional epidermal barrier, he explained. 

Dry, rough, uneven skin is a common symptom for many of these hyperkeratolytic conditions, according to Prof. Staubach-Renz. This is characterized by a build-up of cells on the skin’s surface that create an irregular, thick texture. Hyperkeratois commonly presents in patients with conditions like keratosis pilaris, ichythyosis, psoriasis, and atopic dermatitis.  

According to Prof. Staubach-Renz, this is important to understand in order to treat the skin with the proper basic therapy. There are several critical components, and those include mild exfoliation with keratolytics and an occlusive moisturizer. 

Keratolytics break down the outer layers of the skin, which ultimately allow for other topical therapeutics like corticosteroids to penetrate, Dr. Kircik explained. Often, people who are prescribed topical corticosteroid treatments will complain they are unsatisfied and that the treatment is not working. 

“This is where the keratolytics come into the picture, Dr. Kircik said. Compounds like urea and salicylic acid break down that thick skin and allow the topical medication to penetrate. 

Pairing this activity with humectants and an occlusive will support repair of the epidermal barrier by allowing the skin to attract and then retain moisture.  

One over-the-counter skincare system that utilizes this combination of ingredients in a unique timed-release delivery system demonstrated both efficacy and tolerability in two studies cited by Prof. Staubach-Renz, which examined their use in the treatment of keratosis pilaris. 

Researchers found in one study that patients experienced a decrease in transepidermal water loss 1 hour following use of both a cleanser and cream, cell turnover time accelerated at 3-5 days, and 9 of 10 patients subjectively agreed that the skin felt softer, smoother and more comfortable after week 4. In a second study, the severity of dryness, texture and erythema began to improve at two weeks on dermatologic exam. At 8 weeks, skin dryness was reduced by 76%, and there was a visual improvement in roughness and erythema.

 

 

 

 

Heather Onorati is an experienced medical writer and editor with more than 20 years covering the dermatology industry.

 

 

 

 

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Adjunctive Skincare Solutions for Hyperkeratotic Skin Conditions, Including Keratosis Pilaris and Psoriasis

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

This #SkinChat orignally aired on December 16th, 2020. Tune in as Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

Supported By

CeraVe #SkinChat

 

Adjunctive Skincare Solutions for Hyperkeratotic Skin Conditions, Including Keratosis Pilaris and Psoriasis

Featuring Leon Kircik, MD & Prof. Petra Staubach-Renz

Watch On Demand

Join the JDD & CeraVe for this exclusive, on-demand #SkinChat webcast, where Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

This presentation  also includes relevant clinical data supporting the need for ceramides and skin barrier restoration regarding these Keratolytic skin conditions.

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Prof. Petra Staubach-Renz
Senior Physician Dermatology and Allergy
Managing Director, Clinical Research Centre,
Department of Dermatology, University Medical Center
Mainz, Germany
Watch on Vimeo

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

NEW Webinar – What’s New in Acne Management: What We Have Learned from Increased Understanding of Acne Pathophysiology

By JDD Webinars No Comments

Featured Article

Featured Webinar

Join Leon H. Kircik, MD; Linda Stein Gold, MD;  and Jonathan S. Weiss, MD as they discuss the medical interventions that target one or more of the key factors contributing to the development of acne lesions.

  • November 10th, 2020
  • 7:00 PM – 8:00 PM EST
Register Now!

Join Leon H. Kircik, MD; Linda Stein Gold, MD;  and Jonathan S. Weiss, MD as they discuss the medical interventions that target one or more of the key factors contributing to the development of acne lesions.

Acne pathogenesis is multifactorial and not clearly understood; a key factor includes genetics and may result as in interplay of release of inflammatory mediators into the skin, follicular hyperkeratinization with subsequent plugging of the follicle, Cutibacterium acne (C. acnes), formerly Propionibacterium acnes or P. acnes, follicular colonization and excess sebum production.

C. acnes has been shown to mediate inflammatory processes at the site of the sebaceous follicle contributing to the formation of free radical species and generating pro-inflammatory cytokines. Excess sebum production and
C. acnes colonization lead to the formation of microcomedones leading to the development of open or closed comedones, inflammatory papules, pustules and cysts characteristic of acne.
Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), skin current skin care regimen are
factors influencing treatment with classes of topical agents include: comedolytic (anticomedogenic), antimicrobial, antibiotic and antiinflammatory; each impact on the four main pathogenic features of acne.
Join Drs. Leon H. Kircik, Linda Stein Gold, and Jonathan S. Weiss as they discuss the medical interventions generally targeting one or more of the key factors contributing to the development of acne lesions: follicular hyperproliferation and abnormal desquamation (topical and oral retinoids, azelaic acid, salicylic acid, hormonal therapy), increase sebum production (oral isotretinoin, hormonal therapy), C. acnes proliferation (benzoyl peroxide, topical and oral antibiotics, azelaic acid) and inflammation (oral isotretinoin, oral tetracyclines, topical retinoids, azelaic acid).
Register Now!

You May Also Like

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

February issue highlights new perspectives in chronic skin conditions

| Acne, Aesthetics, Featured Articles, JDD Highlights | No Comments
It’s a hopeful time of year, and the articles published in this month’s issue underscore this hope and transition with researchers bringing forward new perspectives on chronic skin conditions like…

NEW Webinar – Differentiating Approach to Acne Therapy: Women Vs. Men

By JDD Webinars No Comments

Featured Article

Featured Webinar

Join Leon H. Kircik, MD and Julie Harper, MD as they discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris.

  • October 27th, 2020
  • 7:00 PM – 8:00 PM EST
Register Now!

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and
treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.
Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.
Register Now!

You May Also Like

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

February issue highlights new perspectives in chronic skin conditions

| Acne, Aesthetics, Featured Articles, JDD Highlights | No Comments
It’s a hopeful time of year, and the articles published in this month’s issue underscore this hope and transition with researchers bringing forward new perspectives on chronic skin conditions like…

Premiere Webinar Event: Recognizing the Role of The Sebaceous Gland in Acne

By JDD Webinars No Comments

Featured Article

Featured Webinar

Join Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD as they discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris.

Register Now!

Join Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD as they discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris.

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Register Now!

You May Also Like

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

February issue highlights new perspectives in chronic skin conditions

| Acne, Aesthetics, Featured Articles, JDD Highlights | No Comments
It’s a hopeful time of year, and the articles published in this month’s issue underscore this hope and transition with researchers bringing forward new perspectives on chronic skin conditions like…

View on Demand: Restoring Skin Barrier Function – Why Formulation Matters

By COVID-19 Webinars, JDD Webinars, Skin Barrier Function No Comments

JDD Multimedia

Webinar Premiere

“Restoring Skin Barrier Function: Why Formulation Matters"

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin.

Tune in as Professor Michael J. Cork BSC MB PhD FRCP and Professor Simon G. Danby discuss the skin-barrier restoring effect of a cream containing ceramides in a multi-vesicular emulsion for people with eczema-prone skin, as well as other skin conditions that require skin-barrier restoration.

Faculty


Professor Michael J. Cork

BSC MB PhD FRCP

Joined the University of Sheffield in 1991 as a lecturer in dermatology whilst continuing as a practising dermatologist for the NHS in Sheffield. Previously, a Registrar in Dermatology at the Royal Hallamshire Hospital, Sheffield, and a Registrar in Respiratory General Medicine at Leeds General Infirmary.

Professor Cork has been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. Major current research work is aimed at identifying gene–environment interactions in the development of atopic dermatitis leading to skin barrier breakdown and the understanding of how topical agents interact with the skin barrier; using this information to enhance the treatment of atopic dermatitis.

Currently the Head of Sheffield Dermatology Research in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield Medical School and Honorary Consultant Dermatologist to both Sheffield Children´s Hospital NHS Foundation Trust and to Sheffield Teaching Hospitals NHS Foundation Trust.

 


Professor Simon G. Danby
PhD, BSC

Originally trained in biochemistry and molecular biology, Professor Danby  joined the University of Sheffield in 2005 as a post-doctoral scientist in the Academic Unit of Biomedical Genetics.

In this position, he worked exclusively for York Pharma on the early stage development of novel therapeutics and diagnostics for atopic dermatitis, psoriasis and malignant melanoma.

In 2009, he joined the Academic Unit of Dermatology Research as a post-doctoral Research Associate. The focus of his research in this role was improving our understanding of the structure and function of the epidermal (skin) barrier and its role in the development of disorders such as atopic dermatitis (AD).

At the beginning of 2012, Professor Danby  was awarded a 3-year unencumbered research fellowship from Johnson & Johnson to continue my research on the skin barrier and set up a dedicated research facility for conducting human skin research.

Since then, he has continued to conduct and lead translational dermatology research as an independent fellow.

Register Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

Starting Your Own Dermatology Practice: Expert Panel Discussion

By JDD Webinars No Comments

JDD Multimedia

Video Pearls

In this exclusive Webcast, expert panelists discuss their experiences with securing financing, choosing devices, hiring contractors and running a practice. They also provide insights into what they wish they knew before beginning their practice, offer practical tips and much more!

 

Supported by

Starting Your Own Dermatology Practice

Expert Panel Discussion

ODAC in partnership with the JDD, invite you to join your dermatology colleagues as we discuss strategies, steps and best practices for starting your own dermatology practice.
In this exclusive Webcast, expert panelists discuss their experiences with securing financing, choosing devices, hiring contractors and running a practice. They also provide insights into what they wish they knew before beginning their practice, offer practical tips and much more!

 

View on Demand Now

MODERATOR

  • Aanand N. Geria, MD, FAAD (Founder, Geria Dermatology – Rutherford, NJ)

PANELISTS

  • Matthew J. Elias, DO, FAAD (Co-Founder, Elias Dermatology – Fort Lauderdale, FL)
  • Rishi K. Gandhi, MD, FAAD (CEO & Director, Ohio Skin Surgery and Cosmetic Center – Dayton, OH)
  • Chesahna Kindred, MD, MBA, FAAD (Founder, Kindred Hair & Skin Center – Columbia, MD)
  • Omar N. Qutub, MD FAAD (Founder, Dermatology By Design LLC – Portland, OR)

View more on-demand webcasts from the JDD.

JDD Webinars

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

Free Webinar: Restoring Skin Barrier Function: Why Formulation Matters

By COVID-19 Webinars, JDD Webinars, Skin Barrier Function No Comments

JDD Multimedia

Webinar Premiere

  • Thursday, July 23rd 2020
  • 12:00 pm EST

Space is limited – secure your spot today!

Register Now!

“Restoring Skin Barrier Function: Why Formulation Matters"

Join the JDD & CeraVe for an Exclusive Premiere Event

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin.

Tune in as Professor Michael J. Cork BSC MB PhD FRCP and Professor Simon G. Danby discuss the skin-barrier restoring effect of a cream containing ceramides in a multi-vesicular emulsion for people with eczema-prone skin, as well as other skin conditions that require skin-barrier restoration.

Space is limited – secure your spot today!

Register Now!

Faculty


Professor Michael J. Cork

BSC MB PhD FRCP

Joined the University of Sheffield in 1991 as a lecturer in dermatology whilst continuing as a practising dermatologist for the NHS in Sheffield. Previously, a Registrar in Dermatology at the Royal Hallamshire Hospital, Sheffield, and a Registrar in Respiratory General Medicine at Leeds General Infirmary.

Professor Cork has been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. Major current research work is aimed at identifying gene–environment interactions in the development of atopic dermatitis leading to skin barrier breakdown and the understanding of how topical agents interact with the skin barrier; using this information to enhance the treatment of atopic dermatitis.

Currently the Head of Sheffield Dermatology Research in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield Medical School and Honorary Consultant Dermatologist to both Sheffield Children´s Hospital NHS Foundation Trust and to Sheffield Teaching Hospitals NHS Foundation Trust.

 


Professor Simon G. Danby
PhD, BSC

Originally trained in biochemistry and molecular biology, Professor Danby  joined the University of Sheffield in 2005 as a post-doctoral scientist in the Academic Unit of Biomedical Genetics.

In this position, he worked exclusively for York Pharma on the early stage development of novel therapeutics and diagnostics for atopic dermatitis, psoriasis and malignant melanoma.

In 2009, he joined the Academic Unit of Dermatology Research as a post-doctoral Research Associate. The focus of his research in this role was improving our understanding of the structure and function of the epidermal (skin) barrier and its role in the development of disorders such as atopic dermatitis (AD).

At the beginning of 2012, Professor Danby  was awarded a 3-year unencumbered research fellowship from Johnson & Johnson to continue my research on the skin barrier and set up a dedicated research facility for conducting human skin research.

Since then, he has continued to conduct and lead translational dermatology research as an independent fellow.

Register Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

View on Demand Now: Systemic and Local Effects of Stress on the Hair Follicle

By COVID-19 Webinars, JDD Webinars No Comments

JDD Multimedia

Video Pearls

Dr. Suneel Chilukuri presents both the systemic and local effects of stress on the hair follicle in this on-demand-video.

Supported by

Systemic and Local Effects of Stress on the Hair Follicle

Proactive Interventions For Stressful Times

Since we understand that hair loss and thinning is an accumulation of multiple factors, this presentation will focus on stress and the pathophysiology of hair loss.

In this on-demand-video, Dr. Suneel Chilukuri presents both the systemic and local effects of stress on the hair follicle. He defines differing pathophysiology between chronic and acute stress and how each directly and indirectly impacts hair. He also defines and discusses the use of stress adaptogens and how to introduce them as part of a comprehensive intervention.

View on Demand Now

SPEAKER

  • Suneel Chilukuri, MD, FAAD, FACMS
  • Director of Cosmetic Surgery, Refresh Dermatology Chief of Dermatology & Dermatologic Surgery, Physician at Sugar Creek

View more on-demand webcasts from the JDD.

JDD Webinars

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…